|
|
||||||||
|
|
|||||||||
|
|
Oncology-Basic Science: Basic ScienceBasic Science Posters |
1 Nuclear Medicine, Beijing University 1st Hospital, Beijing, China
1340
Objectives: The aim of this report is to study the pharmacokinetics and acute toxicity of 99mTc-radiolabeled antisense probe targeting hTERT mRNA.
Methods: One 18mer uniformly phosphorothioate-modified antisense oligonucleotide targeting hTERT mRNA was radiolabeled with 99mTc through bifunctional chelator. Biodistribution of 99mTc-hTERT ASON in KM mice was obtained. The compartment model and pharmacokinetics parameters of 99mTc-hTERT ASON in experimental rabbits were dealt with pharmacokinetics software DAS 2.0.1. The acute toxicity test was performed in KM mice according to the instruction of "Chinese Pharmacopoeia".
Results: The labeling efficiencies of 99mTc-hTERT ASON reached 76%±5%, the specific activity was up to 1850KBq/µg, and the radiochemical purity was above 96%. The biodistribution of 99mTc-hTERT ASON was characterized by quick blood clearance. It accumulated mainly in small intestine, liver, kidney and bladder. Radioactivity counts per minute(CPM) versus time profiles for 99mTc-hTERT ASON were biphasic, indicative of a three-compartment model. The pharmacokinetics parameters of half-life of distribution(T1/2
), half-life of elimination(T1/2β), total apparent volume of distribution(Vd) and total rate of clearance (CL) were 2.04min, 74.94min, 969.66ml, 28.85ml/min respectively. All KM mice were present well after injection of high dose of 99mTc-hTERT ASON, and no mice was dead during the period of 48hr.
Conclusions: These results demonstrate widespread tissue availability of 99mTc-hTERT ASON and suggest its development as a potential molecular imaging agent.
Research Support: The study was supported by National Natural Science Foundation of China (NSFC 30470498 and 30670583), National Basic Research Program (973 Program, 2006CB705705-1) and the second phase of National Education Ministry "985" Project (985-2-056).
| ||||||||||||||||||||||||||||||||||||||